Cognition Therapeutics Inc
NASDAQ:CGTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cognition Therapeutics Inc
NASDAQ:CGTX
|
US |
|
H
|
HPSP Co Ltd
KOSDAQ:403870
|
KR |
|
Acanthe Developpement SE
PAR:ACAN
|
FR |
|
I
|
Inhalerx Ltd
ASX:IRX
|
AU |
|
O
|
Odas Elektrik Uretim Sanayi Ticaret AS
IST:ODAS.E
|
TR |
|
Svenska Cellulosa SCA AB
F:SCA1
|
SE |
|
P
|
Posco M-Tech Co Ltd
KOSDAQ:009520
|
KR |
|
J
|
Jiangmen Kanhoo Industry Co Ltd
SZSE:300340
|
CN |
|
V
|
Vodafone Group PLC
F:VODI
|
UK |
|
Jiangsu Transimage Technology Co Ltd
SZSE:002866
|
CN |
|
P
|
Piotech Inc
SSE:688072
|
CN |
|
Adese Gayrimenkul Yatirim AS
IST:ADESE.E
|
TR |
|
S
|
Stalexport Autostrady SA
WSE:STX
|
PL |
|
I
|
Ilyang Pharmaceutical Co Ltd
KRX:007570
|
KR |
|
Freshii Inc
TSX:FRII
|
CA |
|
S
|
SAS AB
SWB:SSV2
|
SE |
Bankruptcy Probability
Cognition Therapeutics Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cognition Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cognition Therapeutics Inc
NASDAQ:CGTX
|
77.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cognition Therapeutics Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cognition Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
